View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 15, 2021

ERT’s Business Intelligence suite expands to include clinical trial reporting

US-based global data and technology company eResearch Technology (ERT) has announced the expansion of its Business Intelligence suite to include reporting for clinical trial imaging, making study data easily accessible and actionable.

US-based global data and technology company eResearch Technology (ERT) has announced the expansion of its Business Intelligence suite to include reporting for clinical trial imaging, making study data easily accessible and actionable.

With the new imaging capabilities that provide an increased level of information, study leaders will be able to ensure completion, and manage sites, costs, and productivity effectively.

ERT Imaging vice-president Tim Kulbago said: “Imaging studies are complex, and customers are under great pressure to monitor and manage their performance. With the power of our Business Intelligence suite, study leaders can achieve the deep insights they need to act quickly, and keep studies on track for success.

“Our clinical trial imaging customers can now track their study progress all the way from first image capture to database lock, with the ability to pivot with confidence whenever a potential challenge arises.”

With ERT’s Business Intelligence suite, many CROs and sponsors can realise new operational efficiencies and better data quality.

They can also reduce study timelines and lower costs through its comprehensive views into trial performance.

The Business Intelligence suite comprises the new imaging functionality that enables customers to direct studies using existing information.

Furthermore, they have access to an easy-to-understand dashboard to evaluate early indicators of potential delays in the imaging process.

An intuitive interface of the suite allows users to access study data in various methods. Based on region, site and image reader, they can also easily filter data for a high-level view or dive down.

Additionally, through timely information study leaders can intervene as necessary.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU